U.S. Medical Marijuana Market Comprehensive Evaluation with Top Players: Aurora Cannabis Inc., GW Pharmaceuticals plc, Canopy Growth Corporation

The U.S. medical marijuana market for skin-related conditions such as eczema and psoriasis, is forecasted to grow at a very impressive rate of 13.7%. Marijuana has anti-itch, anti-microbial and anti-inflammatory properties, that accelerates the treatment of skin disorders. In addition, marijuana is a better treatment option as compared to other steroid creams which has few side effects including rosacea, thinning of skin, increased blood pressure and blood sugar levels.

The U.S. medical marijuana pain management market held around 75% share of total application market valuation, accounting for a total value of USD 2,691.9 million 2017. Growth is attributed to the increased prevalence of pain-related issues and conditions. According to various research studies in the U.S., 1 in 10 adults suffer from chronic pain each year, which in turn has augmented the application of medical marijuana.

Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/2890

Growing prevalence of pain in the America is driving the U.S. medical marijuana market. As per the National Health Interview Survey (NHIS), approximately 25 million people suffer from pain each day in the U.S. Furthermore, increased research on marijuana's potential for medicinal use is also gaining momentum in the U.S., thereby enhancing the market growth during the forecast period.

Certain obstacles such as side effects associated with medical marijuana and strict regulatory norms will hinder the U.S. medical marijuana market size expansion. Also, difficulty in undertaking medical marijuana business banking will also restrict the market growth in the U.S.

Company profiled in this report based on Business overview, Financial data, Product landscape, Strategic outlook & SWOT analysis:
• Aurora Cannabis Inc.
• GW Pharmaceuticals plc
• Canopy Growth Corporation
• Insys Therapeutics, Inc.
• Tilray
• Aphria Medical Marijuana, Inc.
• Corbus Pharmaceuticals
• United Cannabis Corporation
• Cannabis Sativa Inc

The U.S. medical marijuana dispensaries market segment generated value of USD 2,144.3 million in 2017. Increasing incidence of pain cases in the U.S. coupled with growing demand for medical marijuana is driving the segment growth. Moreover, dispensaries are authorized bodies abiding by the local government rules, hence maximizing the sales of marijuana through dispensaries.

Pacific Central medical marijuana market was valued at USS 2,085.9 million in 2017. Presence of states such as California, Washington and Alaska and increased application of medical marijuana is driving the market growth in the region. California led the U.S. in legalization of medical marijuana since 1996. Moreover, majority of medical patients reside in California with more than 261 dispensaries, hence adding up to the revenue of Pacific Central medical marijuana market.

Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/2890

New Hampshire medical marijuana market is forecasted to expand at 24.1% CAGR during the forecast period. New Hampshire ranked second in the country for the highest opioid overdose rate. With the legalization of medical marijuana, it will result in improvement of health outcomes for individuals suffering from pain, thereby driving the segment growth in the long run.

U.S. Medical Marijuana Market by Application
• Pain Management
• Neuropathic Pain
• Cancer Pain
• Others
• Muscle Spasms
• Nausea
• Anorexia
• Seizures

Global Market Insights Inc. is a global market research and management consulting company catering to leading corporations, non-profit organizations, universities and government institutions. Our main goal is to assist and partner organizations to make lasting strategic improvements and realize growth targets. Our industry research reports are designed to provide granular quantitative information, combined with key industry insights, aimed at assisting sustainable organizational development.

Global Market Insights, Inc.
4 North Main Street
Selbyville, Delaware 19975 USA
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email:sales@gminsights.com

This release was published on openPR.